Cytogenetically defined myelodysplasia after melphalan-based autotransplantation for multiple myeloma linked to poor hematopoietic stem-cell mobilization: the Arkansas experience in more than 3000 patients treated since 1989

Myelodysplastic syndrome (MDS) is a well-recognized complication of chemotherapy for multiple myeloma (MM). Serial bone marrow metaphase examinations were performed for MM restaging in 3077 patients undergoing high-dose therapy (HDT). MDS-associated cytogenetic abnormalities (MDS-CAs) were observed...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Barlogie, Bart, Tricot, Guido, Haessler, Jeff, van Rhee, Frits, Cottler-Fox, Michele, Anaissie, Elias, Waldron, James, Pineda-Roman, Mauricio, Thertulien, Raymond, Zangari, Maurizio, Hollmig, Klaus, Mohiuddin, Abid, Alsayed, Yazan, Hoering, Antje, Crowley, John, Sawyer, Jeffrey
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2008
Matèries:
Clinical Trials and Observations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2200826/
https://ncbi.nlm.nih.gov/pubmed/17895401
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2007-06-097444
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars